Bordetella pertussis virulence factors affect phagocytosis by human neutrophils

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1735-1739

  Weingart, Christine L ^a   Weiss, Alison A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ANTIBODY; FC RECEPTOR; HEMAGGLUTININ; PERTACTIN; PERTUSSIS TOXIN; VIRULENCE FACTOR;

ARTICLE; BACTERIUM ADHERENCE; BACTERIUM MUTANT; BORDETELLA PERTUSSIS; HUMAN; HUMAN CELL; NEUTROPHIL; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADHESINS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL OUTER MEMBRANE PROTEINS; BORDETELLA PERTUSSIS; HEMAGGLUTININS; HUMANS; NEUTROPHILS; OPERON; OPSONIN PROTEINS; PHAGOCYTOSIS; VIRULENCE; VIRULENCE FACTORS, BORDETELLA;

EID: 0033956166     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1735-1739.2000     Document Type: Article

References (44)

1. Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet 1:955-960.
2. Allen, A., and D. Maskell. 1996. The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol. Microbiol. 19:37-52.
3. Antoine, R., and C. Locht. 1990. Roles of the disulfide bond and the carboxyterminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Infect. Immun. 58:1518-1526.
4. Arico, B., J. F. Miller, C. Roy, S. Stibitz, D. Monack, S. Falkow, R. Gross, and R. Rappuoli. 1989. Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc. Natl. Acad. Sci. USA 86:6671-6675.
5. Banemann, A., and R. Gross. 1997. Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes. Infect. Immun. 65: 3469-3473.
6. Bauer, M. E., and R. A. Welch. 1997. Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysin. Infect. Immun. 65:2218-2224.
7. Cherry, J. D., J. Gornbein, U. Heininger, and K. Stehr. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901-1906.
8. Chhatwal, G. S., M. J. Walker, H. Yan, K. N. Timmis, and C. A. Guzman. 1997. Temperature dependent expression of an acid phosphatase by Bordetella bronchiseptica: role in intracellular survival. Microb. Pathog. 22:257-264.
9. Confer, D. L., and J. W. Eaton. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217:948-950.
10. Craig, F. F., J. M. Lackie, R. Parton, and J. H. Freer. 1988. Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and intact bacteria. J. Gen. Microbiol. 134:2201-2211.
11. Fernandez, R. C., and A. A. Weiss. 1994. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect. Immun. 62:4727-4738.
12. Fernandez, R. C., and A. A. Weiss. 1998. Serum resistance in bvg-regulated mutants of Bordetella pertussis. FEMS Microbiol. Lett. 163:57-63.
13. Finn, T. M., and L. A. Stevens. 1995. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol. Microbiol. 16:625-634.
14. Finn, T. M., and D. F. Amsbaugh. 1998. Vag8, a Bordetella pertussis bvg-regulated protein. Infect. Immun. 66:3985-3989.
15. Friedman, R. L., K. Nordensson, L. Wilson, E. T. Akporiaye, and D. E. Yocum. 1992. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect. Immun. 60:4578-4585.
16. Geuijen, C. A. W., R. J. L. Willems, M. Bongaerts, J. Top, H. Gielen, and F. R. Mooi. 1997. Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect. Immun. 65: 4222-1228.
17. Goodwin, M. S. M., and A. A. Weiss. 1990. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice. Infect. Immun. 58:3445-3447.
18. Gueirard, P., A. Druilhe, M. Pretolani, and N. Guiso. 1998. Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect. Immun. 66:1718-1725.
19. Guzman, C. A., M. Rohde, and K. N. Timmis. 1994. Mechanisms involved in uptake of Bordetella bronchiseptica by mouse dendritic cells. Infect. Immun. 62:5538-5544.
20. Guzman, C. A., M. Rohde, M. Bock, and K. N. Timmis. 1994. Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells. Infect. Immun. 62:5528-5537.
21. Hewlett, E. L. 1997. Pertussis: current concepts of pathogenesis and prevention. Pediatr. Infect. Dis. J. 16(4 suppl.):S78-S84.
22. Hewlett, E. L., and S. A. Halperin. 1998. Serological correlates of immunity to Bordetella pertussis. Vaccine 16:1899-1900.
23. Hewlett, E. L., M. A. Urban, C. R. Manclark, and J. Wolff. 1976. Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc. Natl. Acad. Sci. USA 73:1926-1930.
24. Khelef, N., C.-M. Bachelet, B. B. Vargaftig, and N. Guiso. 1994. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect. Immun. 62:2893-2900.
25. Lee, S.-J., M. C. Gray, L. Guo, P. Sebo, and E. L. Hewlett 1999. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 67:2090-2095.
26. Leininger, E., M. Roberts, J. Kenimer, I. Charles, N. Fairweather, P. Novotny, and M. Brennan. 1991. Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc. Natl. Acad. Sci. USA 88:345-349.
27. Lenz, D. H., C. L. Weingart, and A. A. Weiss. 2000. Phagocytosed Bordetella pertussis fails to survive in human neutrophils. Infect. Immun. 68:956-959.
28. Locht, C., P. Bertin, F. D. Menozzi, and G. Renauld. 1993 The filamentous hemagglutinin, a multifaceted adhesin produced by virulent Bordetella spp. Mol. Microbiol. 9:653-660.
29. Mooi, F. R., H. G. J. van der Heide, A. R. ter Avest, K. G. Welinder, I. Livey, B. A. M. van der Zeijst, and W. Gaastra. 1987. Characterization of fimbrial subunits from Bordetella species. Microb. Pathog. 2:473-484.
30. Mussen, J. M., E. L. Hewlett, M. S. Peppler, and R. K. Selander. 1986. Genetic diversity and relationships in populations of Bordetella spp. J. Bacteriol. 166:230-237.
31. Pittman, M. 1979. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev. Infect. Dis. 1:401-112.
32. Plotkin, S. A., and M. Cadoz. 1997. The acellular pertussis vaccine trials: an interpretation. Pediatr. Infect. Dis. J. 16:508-517.
33. Schipper, H., G. F. Krohne, and R. Gross. 1994. Epithelial cell invasion and survival of Bordetella bronchiseptica. Infect. Immun. 62:3008-3011.
34. Steed, L. L., M. Setareh, and R. L. Friedman. 1991. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes. J. Leukoc. Biol. 50:321-330.
35. Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 1998. Levels of anti-penussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916.
36. Torre, D., G. Ferrario, G. Bonetta, L. Perversi, R. Tambini, and F. Speranza. 1994. Effects of recombinant human gamma interferon on intracellular survival of Bordetella pertussis in human phagocytic cells. FEMS Immunol. Med. Microbiol. 9:183-188.
37. Turcotte, M. L., D. Martin, B. R. Brodeur, and M. S. Peppler. 1997. Tn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function. Microbiology 143:2381-2394.
38. Weingart, C. L., G. Broitman-Maduro, G. Dean, S. Newman, M. Peppler, and A. A. Weiss. 1999. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect. Immun. 67:4264-4267.
39. Weiss, A. 1997. Mucosal immune defenses and the response of Bordetella pertussis. ASM News 63:22-28.
40. Weiss, A. A., and M. S. M. Goodwin. 1989. Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect. Immun. 57:3757-3764.
41. Weiss, A. A., E. L. Hewlett, G. A. Myers, and S. Falkow. 1983. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect. Immun. 42:33-41.
42. Weiss, A. A., E. L. Hewlett, G. A. Myers, and S. Falkow. 1984. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J. Infect. Dis. 150:219-222.
43. Weiss, A. A., A. R Melton, K. E. Walker, C. Andraos-Selim, and J. J. Meidl. 1989. Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes. Infect. Immun. 57:2674-2682.
44. Weiss, A. A., P. S. Mobberley, R. C. Fernandez, and C. M. Mink. 1999. Characterization of human bactericidal antibodies to Bordetella pertussis. Infect. Immun. 67:1424-1431.